04:17 PM EDT, 08/12/2024 (MT Newswires) -- Joseph W Laplume, Executive Vice President, Corporate Strategy & Development, on August 08, 2024, sold 1,780 shares in Charles River Laboratories International ( CRL ) for $354,861. Following the Form 4 filing with the SEC, Laplume has control over a total of 22,521 shares of the company, with 22,521 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1100682/000112760224022003/xslF345X03/form4.xml

Price: 190.00, Change: -4.35, Percent Change: -2.24